Davidson Kempner Capital Management LP Atai Life Sciences N.V. Transaction History
Davidson Kempner Capital Management LP
- $4.36 Trillion
- Q4 2024
A detailed history of Davidson Kempner Capital Management LP transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Davidson Kempner Capital Management LP holds 949,373 shares of ATAI stock, worth $2.18 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
949,373Holding current value
$2.18 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
101Shares Held
14.8MCall Options Held
168KPut Options Held
77.9K-
Morgan Stanley New York, NY3.33MShares$7.66 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$4.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$3.01 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$2.26 Million0.0% of portfolio
-
Brown University719KShares$1.65 Million0.44% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $382M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...